Try our Advanced Search for more refined results
Health - June, 2007
150 articles
- Federal Circuit Keeps Takeda's Win Streak Alive
- Dey Buries Hatchet With States In Drug Pricing Suit
- ERISA Preempts MA Agency In Benefits Suit: Judge
- Sales Reps Sue Abbott For Overtime Pay
- Antitrust Case Could Affect Buying Groups
- AstraZeneca Asserts Seroquel Patent Against Teva
- WellPoint Finds Itself on Wrong End Of CFO Sex Suit
- GE Healthcare Sued Over "Toxic" Chemical Dye
- Jailed Scrushy Wants Out Pending Appeal
- Doubt Cast On Anti-Depressant/Birth Defect Link
- Senate Committee Backs Healthcare IT Bill
- Stem Cell Patent Dispute Stayed Until PTO Ruling
- AsymmetRx Sues Rivals Over Cancer Diagnostic Test
- University, Biotechs Squabble Over Genetic Testing
- Attorney Slid Workers $3M To Settle Claims: Suit
- Ortho Evra Plaintiffs' Lawyers Gear Up For Class Action
- FDA, SEC Disclosure: Standard Procedures Can Help
- Judge Halts DNA Patent Suit Pending Settlement
- GSK To Generics: Hands Off Paxil Patents
- Bone Cancer Drug Suits Try To Break Novartis
- Pfizer Doesn't Owe Attorneys' Fees, Court Says
- Court Nixes Pfizer's Bid To Toss Nigeria Suit
- Battle Rages On In Seroquel Case
- J&J Wants Ortho Evra Documents Kept Under Wraps
- Supreme Court Will Hear Regulatory Preemption Case
- After Loss, Drug Makers Move To Toss Separate Case
- Purchasers Seek Class Status In Ditropan Case
- Novogen Settles Patent Spat Over Menopause Patents
- Goldshield Pays £4M To Settle Price-Fixing Allegations
- Tough Road Lies Ahead For Proposed Biologics Bill
- Teva Files Ninth Suit Over Heart Failure Drug
- High Court Refuses To Hear Authorized Generics Suit
- Wyeth Wants To Dump Old PPA Case Files
- Judge Tosses Ephedra Claim
- Wyeth Sues Sandoz Over Generic Effexor
- Teva Sues Over Congestive Heart Failure Drug
- J&J Unit Faces Scrutiny After $5M Jury Loss
- Shelhigh Agrees To Halt Production Of Seized Devices
- Drug Middlemen Pan Judge Over Subpoena Denial
- Alza Challenges Antitrust Claims In Ditropan Case
- Guidant Seeks To Exclude Testimony
- Suits Contend Pfizer Drug Sparks Gambling Addiction
- Tyco Sues Over Medical Fluid Injector Patent
- DenTek Chomps Trade Secret Claims
- Forest Cries Foul In Celexa/Lexapro Filing Chaos
- Judge Finds Drug Makers Liable For Inflating Costs
- Embattled Medical Device Maker Files Ch. 11
- Court Shakes Head At Novartis In Famvir Spat
- Sanofi Fires New Round Of Infringement Claims
- Wyeth Loses First Diet Pill Trial Of 2007
- Plaintiffs Win More Time To Seal Glaxo Deal
- Abbott Sues Impax Over Depakote
- J&J Continues To Face Prosthetic Knee Suits
- House Committee Greenlights Safety Bill
- Chemical Co. Sues Over Transdermal Patch Patent
- Apotex To Appeal Court's Plavix Patent Ruling
- Bellwether Plaintiff Prepares For Guidant Trial
- St. Vincent Wants Solicitation Rights Extended
- DOJ Settles Fee-Fixing Suit With Doctors Union
- U.S., Europe Revamp Drug Regulation Pact
- Israeli Co.'s Appeal Dies at the Supreme Court
- Biomedino's Blood-Cleaning Patent Found Invalid
- J&J Subsidiaries Hope For Another Dismissal
- Prempro Plaintiffs Demand Docs From Wyeth
- Jury Sides With Johns Hopkins In Patent Case
- Forest Tries To Block Plaintiff In Celexa/Lexapro Suits
- Judge Issues Blow To Accutane Plaintiffs
- Alleged Vioxx Deception Earns Attys. $4M
- Becton Dickinson Sued Over Syringe Patents
- Sanofi Fights To Hang On To Eloxatin
- BMS Avoids Charge As Prosecution Deal Expires
- State's Bid To Get Zyprexa Case On Home Turf Denied
- Judge Bounces Bextra, Celebrex Claims
- Supplement Containing Impotence Drug Recalled
- Tyco Unit Challenges OxyContin Patents
- Vet Co. Sues Pfizer Over Drug Marketing Practices
- Attorney Ads Make Mentally Ill Stop Taking Drugs: Lilly
- Plaintiffs Eye Punitive Pay Against Bausch & Lomb
- F.D.A. Panel Rejects Drug for Obesity
- Pharmaceutical Liability Will Turn On Preemption
- Bloomberg Moves To Unseal Guidant Court Papers
- Eisai Patent Win Pains Antitrust Claimants
- Blame Over Fosamax Draws Sharp Debate
- KV Brings Antitrust Allegations To Patent Suit
- Cordis, Abbott Continue Battle Over Stent Patents
- Pfizer Heaps Another $100M Onto Asbestos Trust
- Warner Chilcott Drops $5.5M In Ovcon Settlement
- Ortho-McNeil, Plaintiffs Skirt Calif. Venue
- Suit Against Boston Scientific Officers Dismissed
- Judge Nixes Bids To Toss Heart Device Claims
- Bristol-Myers Bids To Exclude Evidence
- ImClone Fires Counsel Following Sanctions
- Autism Case Sparks Debate Over Vaccine Program
- Lilly Settles Scores Of Zyprexa Suits
- Discovery In Seroquel Cases Gets OK
- Ortho-McNeil Denies Birth-Control Patch Claims
- Medtronic Asserts Corrected Claims Against Cordis
- High Court Nixes Pfizer's Bid For Quick Review
- GSK Faces More Headaches Over Avandia
- Medtronic Braces For Face-Off In Court
- Proveris Wins Permanent Injunction Against Rival
- Express Scripts Gets Fraud Charges Dismissed
- Judge Stays Schering Clarinex Patent Suit
- Court Sanctions ImClone, IP Attorneys
- Pfizer Seeks To Toss Celebrex, Bextra Cases
- Suit Alleges Biotech Firm Lied About FDA Trials
- Teva, Novartis To Compete For Generic Lotrel
- Metabolife Settles More Ephedra Claims
- Purdue Sues KV Over OxyContin Patent
- Court To Hear Ex-Employee's Case Against Pfizer
- Rite Aid Sued Over Alleged Union Suppression
- Plaintiffs Bash Broad Take On Twombly
- AstraZeneca Hit With Wage-And-Hour Suit
- AstraZeneca Settlement Has Consumer Class Split
- Pfizer Sues Teva Over Lipitor Patent
- Judge Denies Fresenius' Bid For Stay In Patent Case
- Congress Weighs Value Of Pediatric Exclusivity
- Novartis Bone Drug Suit Grows
- Companies' Letter Demands Biologic Bill Passage
- Scrushy Wants Judge Out In Corruption Sentencing
- Defamation Suit Against J&J Moved To Federal Court
- Third Circuit Knocks Down AARP Challenge To EEOC
- Appellate Court Remands ERISA Suit Against Guidant
- Hospital District Settles Fraud Suit For $15M
- Judge Rules Pepcid Complete Patent Is Invalid
- Union Sues J&J Over Off-Label Uses Of Risperdal
- Consumers Urge High Court To Hear Tamoxifen Cases
- Pfizer Fights Bid To Keep Bextra Case In State Court
- Cordis Says Medtronic Stent Patents Unenforceable
- Abbott Accused Of Inflating Drug Prices By 1000%
- FDA Commissioner Defends Reaction To Avandia
- Watson, Sun Seek Attorneys' Fees From Novartis
- Nigeria Sues Pfizer For $7B Over Drug Trials
- Proposed Inpatient Rule To Affect Specialty Hospitals
- Circuit Reaffirms Invalidity of Pfizer's Norvasc Patent
- FDA Proposes Committee For Risk Communication
- Rite Aid Acquires 1,800+ Stores With Divestitures
- Pfizer Asks For Quick Review In Norvasc Feud
- EPA Probe Of Power Plant, Health Care Facility Waste
- Barr, Lilly Dismiss Prozac Patent Suit
- Bill Would Fix Federal Privacy Loophole
- Abbott Accuses Health Officials In Medicare Suit
- Judge Says Impax, Apotex Infringed Prilosec Patents
- Lerach Awarded More Than $3M
- Judge Scoffs At UnitedHealth's Bid To Toss Case
- Merck Witness' Omission Leads To New Vioxx Trial
- More Sales Reps Join Novartis Overtime Lawsuit
- Glaxo Slapped With Avandia Personal Injury Suit
- Express Scripts Sued Over Patient ID Cards
- N.Y. Hospital Closings Unconstitutional, Lawyers Say